Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CTIC $0.40 0.0520 +14.86%
THLD $1.01 0.1100 +12.22%
ARGS $5.22 0.3600 +7.41%
VRML $1.42 0.0900 +6.77%
ARRY $3.44 0.2000 +6.17%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

MNKD $0.75 -0.0440 -5.58%
KERX $4.32 -0.2500 -5.47%
MTP $4.18 -0.2200 -5.00%
SNSS $0.88 -0.0400 -4.35%
LBIO $8.20 -0.3700 -4.32%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Procedure Providing Hope for Some Brain Cancer Patients

(Mississipi Business Journal) Aug 4, 2016 - Tiny electrical fields that help your cells communicate are being harvested at the University of Mississippi Medical Center to fight a type of brain cancer that primarily strikes adults.
read article 



Duke Team Identifies New ‘Mega-Complex’ Involved in Cell Signaling

(Duke Medicine) Aug 4, 2016 - Duke Health-led researchers have discovered new iformation about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
read press release 



Scientists Rehash Evidence On Sunscreen and Skin Cancer

(Reuters) Aug 4, 2016 - There isn’t much evidence to conclusively prove that daily sunscreen use can prevent most skin cancers, a research review concludes.
read article 



Leukemia in Remission for First Patient to Undergo CAR T-Cell Immunotherapy in San Diego

(UC San Diego) Aug 4, 2016 - Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia (ALL). This year, at age 27, his leukemia returned for the fourth time. This time was different, though — on May 20, 2016, Legaspi became the first patient in San Diego to receive a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health.
read article 



A Survival 'Paradox' in Colon Cancer

(Medscape Medical News) Aug 5, 2016 - There is a "survival paradox" in colon cancer? patients with a lower-stage malignancy have poorer survival than patients with higher-stage disease? and a new study confirms the phenomenon.
read article (free registration required) 



Analysis of Metastatic Prostate Cancers Suggests Treatment Options

(UC Santa Cruz) Aug 4, 2016 - Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
read article 



Cancer Gene Tests 'Reveal Family Link'

(BBC News) Aug 5, 2016 - Scientists have discovered why some families are affected by many different types of cancer, thanks to genetic testing.
read article 



Bristol-Myers' Opdivo Fails Lung Cancer Trial; Shares Plunge

(Reuters) Aug 5, 2016 - Bristol-Myers Squibb Co said its blockbuster Opdivo immunotherapy failed to slow progression of symptoms in previously untreated patients with advanced lung cancer in a late-stage study, a major setback expected to benefit Merck & Co's rival medicine.
read article 



Sanofi Gains EU Approval for Boehringer Consumer Health Unit Buy

(Reuters) Aug 4, 2016 - French drugmaker Sanofi secured EU antitrust approval on Thursday for its proposed buy of German peer Boehringer Ingelheim's consumer health business after agreeing to divest businesses from both companies in nine EU countries.
read article 



U.S. Health Researchers Test Zika Vaccine As Funds Run Low

(Reuters) Aug 3, 2016 - U.S. government researchers said on Wednesday they have begun their first clinical trial of a Zika vaccine while the Obama administration told lawmakers funds to fight the virus would run out in the coming weeks due to congressional inaction.
read article 



Aetna Is Notifying Some Doctors About Their Drug-Dispensing Habits

(Washington Post/To Your Health) Aug 3, 2016 - The giant health insurer Aetna is now actively encouraging change. Using the vast amount of data it collects from insurance claims by pharmacies, it has begun contacting doctors whose prescribing habits are far outside the norm.
read article (free registration required) 



Drug Lobby Plans Counterattack on Prices

(Politico) Aug 4, 2016 - Washington’s powerful drug lobby is gearing up to spend hundreds of millions of dollars on a post-election ad war pushing back against politicians from both parties who have savaged its members over drug prices.
read article 



The American Society of Hematology Honors Charles Mullighan, MD, MBBS (Hons) with the 2016 William Dameshek Prize

(ASH) Aug 4, 2016 - The American Society of Hematology will present the 2016 William Dameshek Prize to Charles Mullighan, MBBS (Hons), MD, of St. Jude Children’s Research Hospital for his leadership in defining the landscape of genetic alterations of acute lymphocytic leukemia (ALL), which has provided valuable insight into the genetic basis of this disease, and in particular high risk and relapsed ALL in children and adults.
read press release 



The American Society of Hematology Honors J. Evan Sadler, MD, PhD, and Ayalew Tefferi, MD, with the 2016 Henry M. Stratton Medal

(ASH) Aug 4, 2016 - The American Society of Hematology (ASH) will recognize J. Evan Sadler, MD, PhD, of Washington University School of Medicine in St. Louis, and Ayalew Tefferi, MD, of Mayo Clinic College of Medicine, with the 2016 Henry M. Stratton Medal for their seminal contributions in the areas of basic and clinical/translational hematology research, respectively.
read press release 



The American Society of Hematology Honors Accomplishments of Thalia Papayannopoulou, MD, with Wallace H. Coulter Award for Lifetime Achievement in Hematology

(ASH) Aug 4, 2016 - The American Society of Hematology (ASH) will recognize Thalia Papayannopoulou, MD, of the University of Washington in Seattle with the 2016 Wallace H. Coulter Award for Lifetime Achievement in Hematology.
read press release 



New Text-Mining Tool Lets Researchers Visualize Gene, Protein, Drug And Disease Connections

(UCCC/Colorado Cancer Blogs) Aug 3, 2016 - Free Chrome plugin developed in the A.C. Tan lab at CU Cancer Center helps researchers map connections between genes, proteins, drugs, diseases.
read article 



Chemotherapy Payment Reform: Medicare Is Missing the Elephant in the Room

(Independent Institute/The Beacon blog [Oakland, CA]) Aug 3, 2016 - Last May I wrote about the uproar over Medicare’s proposed changes to how it will pay doctors who inject drugs at their offices. This largely concerns chemotherapy.
read article 



The Informatics Challenges of the Oncology Care Model

(Healthcare Informatics) Aug 3, 2016 - On July 1, nearly 200 U.S. oncology practices began participating in a new program launched by the Center for Medicare and Medicaid Innovation to encourage higher quality and more coordinated cancer care.
read article 



Marine Drug Goes to Phase III Trials to Treat Lung Cancer

(Labiotech.eu) Aug 4, 2016 - PharmaMar is starting a new Phase III trial, with patients suffering from small cell lung cancer (SCLC). It’ll test the efficacy of its third candidate obtained from marine organisms (PM1183) as a SCLC treatment.
read article 



Calithera Announces Enrollment of First Patient in CB-839 in Combination with Checkpoint Modulator

(NASDAQ) Aug 4, 2016 - Calithera Biosciences, Inc. today announced that the first patient has been enrolled in a Phase 1/2 clinical trial assessing the safety and efficacy of CB-839, a first-in-class glutaminase inhibitor, in combination with nivolumab for the treatment of renal cell carcinoma, malignant melanoma and non-small cell lung cancer.
read article 



Study Finds Marker Of Aggressive Prostate Cancer

(WUSTL) Aug 2, 2016 - The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread, according to new research from Washington University School of Medicine in St. Louis.
read press release 



No Link Between Erectile Dysfunction Drugs, Prostate Cancer: Study

(UPI.com) Aug 2, 2016 - Although there has been some suggestion in studies that erectile dysfunction drugs can lower the risk for prostate cancer, a recent study showed little effect on rates of the disease, researchers report.
read article 



Researchers Inhibit Tumor Growth in New Subtype of Lung Cancer

(BIDMC) Aug 3, 2016 - A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology at Beth Israel Deaconess Medical Center (BIDMC), instructor of medicine at Harvard Medical School and a member of the Harvard Stem Cell Institute, have identified a subtype of human adenocarcinoma.
read press release 



Targeted Therapies Beneficial in KRAS-Mutated NSCLC

(Doctors Lounge/HealthDay News) Aug 3, 2016 - Targeted therapies that do not contain erlotinib can be beneficial for patients with KRAS-mutated (KRAS mut+) advanced non-small-cell lung cancer (NSCLC), according to a study published online Aug. 1 in the Journal of Clinical Oncology.
read article 



Watch and Wait for Kidney Cancer Helps Some to Avoid Toxicity

(Medscape Medical News) Aug 4, 2016 - Some patients with slow-growing metastatic renal cell carcinoma can be safely treated with a "watch and wait" approach, which allows them to avoid the toxicity of noncurative systemic therapy for months or even years, say researchers.
read article (free registration required)